Neuartige Therapien für progrediente Krankheiten
Diese Seite ist zurzeit nur auf Englisch verfügbar.
Advanced therapies, such as nanoscale, gene and cell therapies, offer great potential for improving the lives of people with progressive diseases by helping to replace or regenerate damaged tissue.
Objective: To promote, through interdisciplinary research, the development of advanced therapy technologies and their personalized application in patients with progressive diseases.
Approach: Research initiatives will focus on developing new therapies for use in replacement or regeneration of damaged tissues, genetic modification of stem cells for treatment of rare genetic disorders and cell-based personalized tumor-targeting immunotherapy.
Development: Research into advanced therapies, in particular regenerative therapies, is already underway at BIH, Charité and the Max Delbrück Center for Molecular Medicine. BIH will further merge and develop these areas, targeting funding at new state-of-the-art facilities and the recruitment of researchers.